Tech Company Financing Transactions
Precision Neuroscience Funding Round
On 1/25/2023, Precision Neuroscience received $41 million in Series B funding from Forepont Capital Partners, Alumni Ventures and B Capital Group.
Transaction Overview
Company Name
Announced On
1/25/2023
Transaction Type
Venture Equity
Amount
$41,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds for recruitment of talent, and further product development, paving the road to FDA regulatory review, expected in the coming months.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
54 West 21st St 310
New York, NY 10010
USA
New York, NY 10010
USA
Phone
Undisclosed
Website
Email Address
Overview
We are bringing life-changing brain technology to millions of people. Operating a computer using only your thoughts. It sounds like science fiction, but, in fact, scientists conducted the first successful experiments in brain--computer interface (BCI) technology in the early 2000s. Paralyzed people have used this technology to control robotic arms, play video games, and send messages with their minds alone. But it has yet to move beyond small-scale research settings and into mainstream medical practice. Precision is taking BCIs into the next era -- creating powerful implants that will revolutionize treatment for neurologic disease.
Management Team
Browse more venture capital transactions:
Prev: 1/24/2023: Parable venture capital transaction
Next: 1/25/2023: Emperia venture capital transaction
Share this article
News on VC Transactions
We do our best to document all VC transactions involving tech companies. VC investment data records reported here come from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs